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policy issue 
 
 
 
 
 
Under Australian mental health laws, people with schizophrenia can only be 
involuntarily committed to a mental health facility if they are assessed and it is 
determined that their illness is making them dangerous to themselves or others.[1] 
To determine whether they are to undergo involuntary treatment, mental health 
workers must assess people against an ‘Obligatory Dangerousness Criterion’. This 
criterion is an advance on methods used prior to the mid-1970s, when many 
countries authorised involuntary commitment to a mental health facility on medical 
certification alone, without court approval or any proof of an emergency 
situation.[2]  
An Obligatory Dangerousness Criterion is now widely used in Australia, the USA, and 
some areas of Canada and Europe as the means by which patients are assessed for 
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the appropriateness of involuntary (compulsory) treatment. There is no doubt the 
policy underpinning its use was well intentioned; an Obligatory Dangerousness 
Criterion was originally developed in an attempt to better balance the rights of the 
mentally ill with the need to protect the public. However, over time some experts 
have begun to raise questions about the utility of this criterion, suggesting that it 
sometimes means patients don’t get access to necessary treatment as quickly as 
they should. The problem stems from the fact that in order to be classified as being 
dangerous to themselves or others, people generally need to have a history of 
violence or self-harm, and most patients in their first episode of psychosis do not 
have this kind of history.[3] 
Up to 80 per cent of patients in their first episode of psychosis require inpatient 
treatment early in their illness. In many cases, admission to hospital has to be 
involuntary because few people recognise that their symptoms are due to an 
illness.[3] In community-based treatment, patients sometimes do not adhere to the 
treatment prescribed, and this may lead to consideration of compulsory community 
treatment orders. When people with schizophrenia do not adhere to or consent to 
treatment, their families, friends, mental health professionals and the legal system 
may have to wait for them to threaten, attempt, or complete acts that could, or do, 
result in harm, before they can be involuntarily admitted to hospital, or before 
compulsory community (outpatient) treatment orders are initiated.[4] In these 
circumstances, necessary treatment is delayed, and when psychosis is left untreated 
for lengthy periods, it adversely affects a person’s psychological state and can lead 
to poorer outcomes.[5-7]  
While many countries continue to use an Obligatory Dangerousness Criterion to 
determine whether involuntary treatment is justified, some countries have also 
begun to use other methods: the United Kingdom (UK) and some parts of Canada 
and Europe, for example. In these countries involuntary treatment is permissible 
even if patients have not been assessed as dangerous, but only if they have 
previously been deemed incapable of giving consent when it comes to matters of 
their own health and welfare.[8] As an example, to commit someone with 
schizophrenia to involuntary treatment in the UK, a formal application must be 
made by either an approved mental health professional or the patient’s nearest 
relative. This application is then assessed by two qualified medical practitioners, one 
of whom must be approved for this purpose under the Act.  
With some countries moving away from relying solely on an Obligatory 
Dangerousness Criterion to determine if involuntary treatment is justified, 
Australian policymakers should re-examine current mental health laws. If there are 
other policy options available that make inpatient psychiatric treatment more 
accessible, reduce the duration of untreated psychosis, improve treatment 
outcomes, and reduce dangerous behaviours in people with severe mental illness, 
they should be considered. 
  
what does the 
evidence say? 
 
Systematic reviews that compile the results of multiple independent studies in this 
field have been examined in this Evidence Brief. Because the reviews included in this 
Evidence Brief have adhered to rigorous guidelines for assessing the quality of 
studies included in the review, these systematic reviews provide the most robust 
evidence.[9]  
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Findings from a 2008 systematic review published in Social Psychiatry and 
Psychiatric Epidemiology first raised concerns about the impact of an Obligatory 
Dangerousness Criterion on patient outcomes.[3] To assess its impact, the authors 
of this systematic review compared places where an Obligatory Dangerousness 
Criterion was used with those where it was not. In places where an Obligatory 
Dangerousness Criterion was used (USA, Australia, France, Germany, the 
Netherlands, and Ontario and Quebec in Canada), people tended to have untreated 
psychosis for 80 weeks, on average. In places where it was not used (Denmark, 
Finland, Ireland, UK, Norway, Italy, Spain, and British Columbia and Nova Scotia in 
Canada), the average duration of untreated psychosis was shorter, at 56 weeks. The 
authors of this review concluded that while the duration of untreated psychosis may 
be associated with a range of illness, patient, family and cultural factors, the use of 
an Obligatory Dangerousness Criterion was likely to be partly responsible for the 
longer periods of untreated psychosis seen in this review.  
Two systematic reviews have also been published where the relationships between 
duration of untreated psychosis and clinical and social outcomes were investigated; 
one was published in the Archives of General Psychiatry in 2005 [5] and the other in 
Schizophrenia Research in 2009.[10] In these reviews, researchers found that people 
who had longer periods of untreated psychosis tended to have poorer responses to 
treatment, more severe symptoms, be more disabled by their disease, have poorer 
quality of life, and function at lower levels for up to 2 years after initial treatment. 
They were also less likely to go into remission. Another systematic review, published 
in Social Psychiatry and Psychiatric Epidemiology in 2008, also found that among 
patients experiencing their first episode of psychosis, there was a strong relationship 
between the duration of untreated psychosis and the propensity to commit 
homicide.[6] 
Findings about the impact of untreated psychosis are reasonably consistent across 
studies where short-term outcomes are examined, but the impact over the longer-
term is not clear. There has even been one recent study (published in 2010 in 
Schizophrenia Research) that found people who experienced longer durations of 
untreated psychosis had better outcomes than those with shorter periods of 
psychosis.[11] In this study, researchers followed people over 10 years and found 
that those who experienced longer durations of untreated psychosis were less likely 
to be receiving a disability pension, and spent less time in hospital and more time at 
work. These findings are not terribly robust, however, as the authors suggest that 
the unexpected findings could be due to the small sample size (89 participants) and 
other flaws in the study design.  
The most recent systematic review conducted in this field was done in 2011 by the 
Cochrane Collaboration (an international and independent non-profit organisation 
dedicated to evidence-based health care). The review examined compulsory 
community treatment programs and included two randomised controlled trials 
(RCT) with a total of 416 participants. These trials were conducted in the USA where 
an Obligatory Dangerousness Criterion is used.[12] The findings showed that 
compulsory community treatment programs for patients with severe mental 
illnesses (including schizophrenia spectrum and other psychotic disorders) have no 
benefit over standard outpatient care. There was no demonstrable impact of 
compulsory community treatment programs on reducing hospital admission rates, 
law infringements or homelessness, nor on increasing medication compliance or 
treatment satisfaction. The only possible benefit of compulsory community 
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treatment programs found in this review was a reduction in rates of being a victim 
of criminal activity. 
  
what is the  
quality of the 
evidence available? 
 
The quality of studies in this field is generally good because many of them include a 
large number of patients. Overall, however, the evidence is only considered to be 
moderately robust as many studies show only small to medium effect sizes (a small 
to medium size portion of the patients reviewed show these effects, yet the effects 
are statistically significant).  
Although systematic reviews are considered to be the highest quality evidence, they 
are only ever as good as the studies included in them. For example, the most recent 
2011 Cochrane systematic review on compulsory community treatment programs 
was considered by the review authors to be only of moderate quality.[12] This was 
because the two randomised controlled trials (RCT) it included had certain 
limitations. They did not properly report how people were randomised to groups in 
the study; this is important because researchers need to make sure the group of 
patients receiving treatment is broadly the same as the control group. The studies 
included also did not adequately report how the people assessing outcomes 
remained impartial (or ‘blinded’) as to which study group people were in.  
Despite these limitations, the Cochrane review pooled data from both RCTs and 
found that there was reasonable consistency across studies and little statistical 
variability. This increases the reliability of the findings.  
The three other systematic reviews considered in this Evidence Brief are of lower 
quality because they only include observational studies, not RCTs. The 2008 
systematic review assessing the relationship between the duration of untreated 
psychosis and an Obligatory Dangerousness Criterion included 47 observational 
studies with a total of 5849 participants.[3] The two other systematic reviews 
assessing the relationships between duration of untreated psychosis and clinical and 
social outcomes included 5 observational studies (with 446 participants) [10] and 26 
observational studies (with 446 4490 participants) [5], respectively. Unlike RCTs 
where the randomisation process should make the two study groups broadly 
comparable, observational studies are not able to do this, making them of inherently 
lower quality due to the possible effects of these factors.[13] 
  
what does this  
mean for  
policymakers? 
Australia should examine the criteria used in other jurisdictions for determining 
whether patients with schizophrenia should be committed to involuntary treatment, 
either to inpatient or community services. While the evidence in this field is not 
clear cut, the best available evidence does show that the use of an Obligatory 
Dangerousness Criterion can have a detrimental effect on patients suffering from 
schizophrenia because it can delay timely access to treatment. The criterion has 
been shown to be particularly problematic for patients in their first-episode of 
psychosis, and over the short to medium term. Any impact on long-term outcomes 
for patients is yet to be determined. Because it is likely to be some time before there 
is strong evidence on the long-term impact of an Obligatory Dangerousness 
Criterion, there needs to be a broader discussion in Australia about how we should 
address the challenge of committing people to involuntary treatment when they 
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cannot or will not consent to voluntary treatment. 
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